.jpeg)
What Bortezomib does
Bortezomib (Bortezomib) is a targeted therapy drug mainly used to treat malignant tumors such as multiple myeloma and certain non-Hodgkin lymphomas. Bortezomib is a proteasome inhibitor that acts on the intracellular proteasome structure. Proteasomes are special structures within cells that are responsible for breaking down and degrading proteins. This process is important for maintaining normal cell function and metabolism. However, cancer cells usually require more proteins to support their abnormal growth and proliferation, so they are highly dependent on the activity of the proteasome. Bortezomib alters the intracellular protein degradation process by inhibiting the function of the proteasome.
[ 免责声明 ] 本页面内容来自公开渠道（如FDA官网、Drugs官网、原研药厂官网等），仅供持有医疗专业资质的人员用于医学药学研究参考，不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市，不适用于中国境内销售和使用。如需治疗，请咨询正规医疗机构。本站不提供药品销售或代购服务。
